Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Journey Medical (DERM) Return on Assets: 2021-2025

Historic Return on Assets for Journey Medical (DERM) over the last 4 years, with Sep 2025 value amounting to -0.10%.

  • Journey Medical's Return on Assets rose 18.00% to -0.10% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.10%, marking a year-over-year increase of 18.00%. This contributed to the annual value of -0.19% for FY2024, which is 14.00% down from last year.
  • Per Journey Medical's latest filing, its Return on Assets stood at -0.10% for Q3 2025, which was up 1.01% from -0.10% recorded in Q2 2025.
  • Journey Medical's 5-year Return on Assets high stood at 0.01% for Q2 2024, and its period low was -0.47% during Q2 2023.
  • In the last 3 years, Journey Medical's Return on Assets had a median value of -0.10% in 2025 and averaged -0.18%.
  • The largest annual percentage gain for Journey Medical's Return on Assets in the last 5 years was 49bps (2024), contrasted with its biggest fall of 15bps (2024).
  • Quarterly analysis of 5 years shows Journey Medical's Return on Assets stood at -0.47% in 2021, then increased by 19bps to -0.28% in 2022, then increased by 22bps to -0.05% in 2023, then fell by 15bps to -0.20% in 2024, then rose by 18bps to -0.10% in 2025.
  • Its last three reported values are -0.10% in Q3 2025, -0.10% for Q2 2025, and -0.10% during Q1 2025.